Johnson & Johnson Firefly Bio Acquisition | Lucid Diligence Brief
Johnson & Johnson's $1 billion Firefly Bio acquisition highlights a…
Neuroscience Today—July 1, 2026
This week’s Neuroscience update highlights regulatory progress, clinical trial…
Immunology Today—July 1, 2026
This week’s Immunology update highlights regulatory decisions, clinical trial…
Hematology Today—June 29, 2026
This week’s Hematology update highlights regulatory progress, advancing…
Rare Diseases Today—June 18, 2026
This week’s Rare Diseases update highlights clinical progress across endocrine…
Oncology Today—June 15, 2026
This week’s Oncology update highlights regulatory authorizations, clinical…
Immunology Today—June 10, 2026
This week’s Immunology update highlights regulatory progress, clinical data on…
Immunology Today—June 3, 2026
This week’s Immunology update highlights regulatory and clinical developments…
Hematology Today—June 2, 2026
This week’s Hematology update highlights ASCO 2026 readouts, regulatory…
Lucid Diligence Brief: Polyphonic Intelligent OR Network Launched by J&J for AI-Powered Surgery
Lucid Diligence Brief: Polyphonic Intelligent OR Network by J&J uses AI to…
Oncology Today—May 18, 2026
This week’s Oncology update highlights regulatory approvals, breakthrough…
Cardiovascular Today—May 14, 2026
This week’s Cardiovascular update highlights clinical progress, device…